Phadia AB Introduces ImmunoCAP(R) Molecular Allergy and Two New Fully Automated, High Throughput Instrument Platforms at the American Association for Clinical Chemistry Annual Meeting

ATLANTA--(BUSINESS WIRE)--Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.